ECM
ETrade Capital Management Portfolio holdings
AUM
$5.37B
1-Year Return
10.85%
This Quarter Return
+16.76%
1 Year Return
+10.85%
3 Year Return
+26.29%
5 Year Return
+59.04%
10 Year Return
–
AUM
$4.79B
AUM Growth
+$872M
(+22%)
Cap. Flow
+$266M
Cap. Flow
% of AUM
5.56%
Top 10 Holdings %
Top 10 Hldgs %
41.72%
Holding
937
New
183
Increased
268
Reduced
394
Closed
90
Top Buys
Top Sells
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$44.8M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$32.2M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$29.1M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$27.6M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$25.7M |
Sector Composition
| 1 | Technology | 5% |
| 2 | Healthcare | 3.89% |
| 3 | Financials | 3.07% |
| 4 | Consumer Discretionary | 2.4% |
| 5 | Industrials | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGIO
751
DELISTED
Edgio, Inc. Common Stock
EGIO
| $219K | ﹤0.01% |
+745
| New | +$219K |
|
752
Amphenol
APH
$146B
| $218K | ﹤0.01% |
+9,112
| New | +$218K |
|
753
CME Group
CME
$93.5B
| $218K | ﹤0.01% |
1,340
-343
| -20% | -$55.8K |
|
754
Stride
LRN
$7.06B
| $217K | ﹤0.01% |
+7,982
| New | +$217K |
|
755
Evercore
EVR
$12.7B
| $216K | ﹤0.01% |
+3,662
| New | +$216K |
|
756
Regeneron Pharmaceuticals
REGN
$58.9B
| $216K | ﹤0.01% |
346
-343
| -50% | -$214K |
|
757
COPT Defense Properties
CDP
$3.45B
| $215K | ﹤0.01% |
+8,501
| New | +$215K |
|
758
Sarepta Therapeutics
SRPT
$1.85B
| $215K | ﹤0.01% |
1,344
-732
| -35% | -$117K |
|
759
Clearway Energy Class A
CWEN.A
$3.19B
| $214K | ﹤0.01% |
+10,211
| New | +$214K |
|
760
Oshkosh
OSK
$8.74B
| $214K | ﹤0.01% |
+2,981
| New | +$214K |
|
761
Skyworks Solutions
SWKS
$10.8B
| $213K | ﹤0.01% |
+1,667
| New | +$213K |
|
762
Neurocrine Biosciences
NBIX
$14B
| $212K | ﹤0.01% |
+1,737
| New | +$212K |
|
763
Constellation Brands
STZ
$25.3B
| $212K | ﹤0.01% |
1,213
-725
| -37% | -$127K |
|
764
Fiserv
FI
$72B
| $210K | ﹤0.01% |
2,154
-4,592
| -68% | -$448K |
|
765
Regal Rexnord
RRX
$9.49B
| $210K | ﹤0.01% |
+2,401
| New | +$210K |
|
766
Jack Henry & Associates
JKHY
$11.7B
| $209K | ﹤0.01% |
+1,136
| New | +$209K |
|
|
RDS.A
767
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $209K | ﹤0.01% |
+6,382
| New | +$209K |
|
768
Avantor
AVTR
$8.71B
| $208K | ﹤0.01% |
+12,244
| New | +$208K |
|
769
Cadence Bank
CADE
$6.92B
| $208K | ﹤0.01% |
+9,156
| New | +$208K |
|
|
NVRO
770
DELISTED
NEVRO CORP.
NVRO
| $208K | ﹤0.01% |
+1,738
| New | +$208K |
|
771
Ametek
AME
$43.2B
| $207K | ﹤0.01% |
2,319
-7,506
| -76% | -$670K |
|
772
Invesco Zacks Multi-Asset Income ETF
CVY
$118M
| $207K | ﹤0.01% |
12,617
-2,202
| -15% | -$36.1K |
|
773
Sensata Technologies
ST
$4.59B
| $207K | ﹤0.01% |
+5,568
| New | +$207K |
|
|
PDM
774
Piedmont Realty Trust, Inc.
PDM
$1.07B
| $206K | ﹤0.01% |
12,427
-365
| -3% | -$6.05K |
|
|
AZPN
775
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $206K | ﹤0.01% |
+1,984
| New | +$206K |
|